The "EPR", dated 28 May, is out. It is a serious attempt, IMO, to outline business plans. While I am FRUSTRATED AS HECK by the company's failure to describe any attempt to reacquire the GTI/Sandoz/Novartis license (or to describe reasons why such would not be desireable), I am, first blush, pleased with the outline.
Looks like things will kick off with a big push to develop the periodontal diagnostic, and periodontal disease has made some nice news of late. Remember that this diagnostic effort is a collaboration with Techne (R&D Systems). I'll see if I can find some links of interest within the next couple of days.
There are distinct weaknesses, from my perspective, in the report. However, in general, I am pleased. Clinical trials of the diagnostic are projected to begin this summer (yes, soon!) and attention is called to the phase I trial in Australia of PAI-2. Call Hal Smith for your copy?
Everyone will love this part........ with a cover sheet and table of contents, it actually arrives (thanks, Jim!) as an "eight page report". ;-) Let's hope that they are quicker at the bench than at the keyboard...............
Rick |
